{"words": ["alzheimer", "disease", "ad", "common", "form", "dementia", "characterized", "accumulation", "amyloid", "\u03b2", "a\u03b2", "neurofibrillary", "tangles", "oxidative", "stress", "inflammation", "considered", "play", "important", "role", "development", "progression", "ad", "however", "extent", "events", "contribute", "a\u03b2", "pathologies", "remains", "unclear", "performed", "comparative", "gene", "expression", "profiling", "ad", "patient", "brains", "app", "mouse", "models", "genes", "commonly", "altered", "app", "human", "ad", "cortices", "correlated", "inflammatory", "response", "immunological", "disease", "among", "expression", "genes", "cd74", "ctss", "gfap", "nfe2l2", "phyhd1", "s100b", "tf", "tgfbr2", "vim", "increased", "app", "cortex", "a\u03b2", "amyloidosis", "progressed", "exacerbated", "gliosis", "genes", "commonly", "altered", "human", "ad", "cortices", "correlated", "neurological", "disease", "app", "cortex", "also", "altered", "expression", "genes", "abi3", "apoe", "bin2", "cd33", "ctsc", "dock2", "fcer1g", "frmd6", "hck", "inpp5d", "ly86", "plcg2", "trem2", "tyrobp", "defined", "risk", "factors", "ad", "association", "study", "identified", "genetic", "nodes", "ad", "results", "suggest", "strong", "correlation", "cortical", "a\u03b2", "amyloidosis", "neuroinflammatory", "response", "provide", "better", "understanding", "involvement", "gender", "effects", "development", "ad"], "authors": [["Castillo", "Erika", "E", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Leon", "Julio", "J", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Mazzei", "Guianfranco", "G", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Abolhassani", "Nona", "N", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Haruyama", "Naoki", "N", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Saito", "Takashi", "T", "Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan."], ["Saido", "Takaomi", "T", "Laboratory for Proteolytic Neuroscience, RIKEN Brain Science Institute, Saitama, Japan."], ["Hokama", "Masaaki", "M", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Iwaki", "Toru", "T", "Department of Neuropathology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Ohara", "Tomoyuki", "T", "Department of Neuropsychiatry, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Ninomiya", "Toshiharu", "T", "Department of Epidemiology and Public Health, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["Kiyohara", "Yutaka", "Y", "Hisayama Research Institute for Lifestyle Diseases, Hisayama, Fukuoka, Japan."], ["Sakumi", "Kunihiko", "K", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan."], ["LaFerla", "Frank M", "FM", "Department of Neurobiology and Behavior, University of California, Irvine, CA, 92697, USA."], ["Nakabeppu", "Yusaku", "Y", "Division of Neurofunctional Genomics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. yusaku@bioreg.kyushu-u.c.jp."]], "title": "Comparative profiling of cortical gene expression in Alzheimer's disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation.", "year": null, "sentences": ["Alzheimer's disease (AD) is the most common form of dementia, characterized by accumulation of amyloid \u03b2\u00a0(A\u03b2) and neurofibrillary tangles.", "Oxidative stress and inflammation are considered to play an important role in the development and progression of AD.", "However, the extent to which these events contribute to the A\u03b2 pathologies remains unclear.", "We performed inter-species comparative gene expression profiling between AD patient brains and the App NL-G-F/NL-G-F and 3xTg-AD-H mouse models.", "Genes commonly altered in App NL-G-F/NL-G-F and human AD cortices correlated with the inflammatory response or immunological disease.", "Among them, expression of AD-related genes (C4a/C4b, Cd74, Ctss, Gfap, Nfe2l2, Phyhd1, S100b, Tf, Tgfbr2, and Vim) was increased in the App NL-G-F/NL-G-F cortex as A\u03b2 amyloidosis progressed with exacerbated gliosis, while genes commonly altered in the 3xTg-AD-H and human AD cortices correlated with neurological disease.", "The App NL-G-F/NL-G-F cortex also had altered expression of genes (Abi3, Apoe, Bin2, Cd33, Ctsc, Dock2, Fcer1g, Frmd6, Hck, Inpp5D, Ly86, Plcg2, Trem2, Tyrobp) defined as risk factors for AD by genome-wide association study or identified as genetic nodes in late-onset AD.", "These results suggest a strong correlation between cortical A\u03b2 amyloidosis and the neuroinflammatory response and provide a better understanding of the involvement of gender effects in the development of AD."], "id": "29259249", "text": "Alzheimer's disease (AD) is the most common form of dementia, characterized by accumulation of amyloid \u03b2\u00a0(A\u03b2) and neurofibrillary tangles. Oxidative stress and inflammation are considered to play an important role in the development and progression of AD. However, the extent to which these events contribute to the A\u03b2 pathologies remains unclear. We performed inter-species comparative gene expression profiling between AD patient brains and the App NL-G-F/NL-G-F and 3xTg-AD-H mouse models. Genes commonly altered in App NL-G-F/NL-G-F and human AD cortices correlated with the inflammatory response or immunological disease. Among them, expression of AD-related genes (C4a/C4b, Cd74, Ctss, Gfap, Nfe2l2, Phyhd1, S100b, Tf, Tgfbr2, and Vim) was increased in the App NL-G-F/NL-G-F cortex as A\u03b2 amyloidosis progressed with exacerbated gliosis, while genes commonly altered in the 3xTg-AD-H and human AD cortices correlated with neurological disease. The App NL-G-F/NL-G-F cortex also had altered expression of genes (Abi3, Apoe, Bin2, Cd33, Ctsc, Dock2, Fcer1g, Frmd6, Hck, Inpp5D, Ly86, Plcg2, Trem2, Tyrobp) defined as risk factors for AD by genome-wide association study or identified as genetic nodes in late-onset AD. These results suggest a strong correlation between cortical A\u03b2 amyloidosis and the neuroinflammatory response and provide a better understanding of the involvement of gender effects in the development of AD.", "doi": "10.1038/s41598-017-17999-3", "journal": ["Scientific reports", "Sci Rep"], "date": "2018-01-18_23:42:30"}